Drug & supplement interaction

Cannabidiol (cbd) + Lenvatinib

Lenvatinib brand name: Lenvima.

No Known Interaction
Medically reviewed by · Updated July 2026 · Pair last verified Sep 13, 2026
The bottom line No known interaction

We found no known interaction between Cannabidiol (cbd) and Lenvatinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Facebook Post Reddit Email
On this page
Interaction report

Cannabidiol (cbd) and Lenvatinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Lenvatinib and Cannabidiol (cbd) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Cannabidiol (cbd) safety at a glance

Cannabidiol (cbd) overall Use caution CBD is generally well tolerated but can cause side effects and quality varies between products.
Pregnancy Possibly Unsafe When used orally. The US Food and Drug Administration (FDA) strongly advises against the use of cannabidiol during pregnancy. Cannabidiol products might contain... Read the full pregnancy detail
Breastfeeding Possibly Unsafe When used orally. The US Food and Drug Administration (FDA) strongly advises against the use of cannabidiol during pregnancy. Cannabidiol products might contain... Read the full breastfeeding detail

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Lenvatinib and Cannabidiol (cbd)? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Lenvatinib

Interactions in our licensed database are recorded against drug classes, not just single drug names. Lenvatinib is filed under 4 classifications — including qt interval-prolonging drugs, nephrotoxic drugs, hepatotoxic drugs. Cannabidiol (cbd) has documented interactions with 37 drug classes — the most serious being brivaracetam (briviact) (moderate), caffeine (moderate) and carbamazepine (tegretol) (moderate) — and none of Lenvatinib’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Cannabidiol (cbd) Does Interact With Other Medications

Cannabidiol (cbd) has 1,051 moderate known drug interactions in our database — Lenvatinib isn’t one of them. If you take anything else, check it against the full list below.

Moderate 1,051 No known interaction 1,779 (incl. Lenvatinib)
Taking anything else?

Check Another of Your Medications Against Cannabidiol (cbd)

Covers the 2,830 medications we’ve checked against Cannabidiol (cbd). Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Cannabidiol (cbd) and Lenvatinib May Share Several of the Same Side Effects

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do. 4 of them are worth acting on rather than waiting out — marked below.

  • Raised blood pressure Worth acting on Additional detail

    Cannabidiol (cbd)

    “Orally, cannabidiol has been associated with cardiovascular effects in some reports. In one clinical study, some patients experienced hypotension, orthostatic hypotension, and lightheadedness. Also, cannabidiol has also been linked to tachycardia and hypertension.”

    Cannabidiol (cbd) · Natural Medicines adverse-effect record, reported in hypertension.

    6 sources cited
    1. 89700. Consroe P, Sandyk R, Snider SR. Open label evaluation of cannabidiol in dystonic movement disorders. Int J Neurosci 1986;30(4):277-82. PubMed
    2. 105493. Berger BA, Stolz U, Colvin J, Otten EJ. Epidemiology of cannabidiol related cases reported in the National Poison Data System - 2019-2020. Am J Emerg Med. 2021;48:218-223. PubMed
    3. 110248. Perez-Vilar S, Karami S, Long K, Leishear K. Cannabidiol exposures in the United States, National Poison Data System, July 2014-June 2021. Clin Toxicol (Phila) 2022. PubMed
    4. 61832. Consroe, P., Laguna, J., Allender, J., Snider, S., Stern, L., Sandyk, R., Kennedy, K., and Schram, K. Controlled clinical trial of cannabidiol in Huntington's disease. Pharmacol Biochem.Behav. 1991;40(3):701-708. PubMed
    5. 89675. Bergamaschi MM, Queiroz RH, Chagas MH, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology 2011;36(6):1219-26. PubMed
    6. 89909. Zuardi AW, Cosme RA, Graeff FG, Guimaraes FS. Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol 1993;7(1 Suppl):82-8. PubMed

    Lenvatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lenvatinib. Read the label on DailyMed ›

  • Shortness of breath Worth acting on Additional detail

    Cannabidiol (cbd)

    “Orally, cannabidiol oil has been associated with rare respiratory depression and increased odds of pneumonia. In a case report, a 56-year-old obese male presented to the emergency room with severe respiratory depression 3 hours after consuming two packages of gummies labeled to contain cannabidiol 370 mg. Symptoms included respiratory acidosis, slurred speech, bradycardia, and vomiting.”

    Cannabidiol (cbd) · Natural Medicines adverse-effect record, reported in cancer.

    6 sources cited
    1. 103029. Bass J, Linz DR. A Case of Toxicity from Cannabidiol Gummy Ingestion. Cureus. 2020;12(4):e7688. PubMed
    2. 103031. Chesney E, Oliver D, Green A, et al. Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology. 2020. PubMed
    3. 106631. Patel AD, Mazurkiewicz-Beldzinska M, Chin RF, et al. Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial. Epilepsia 2021;62(9):2228-2239. PubMed
    4. 106633. Scheffer IE, Halford JJ, Miller I, et al. Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial. Epilepsia 2021;62(10):2505-2517. PubMed
    5. 110247. Hardy J, Greer R, Huggett G, Kearney A, Gurgenci T, Good P. Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). J Clin Oncol 2022. PubMed
    6. 61759. Rog, D. J., Nurmikko, T. J., Friede, T., and Young, C. A. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 9-27-2005;65(6):812-819. PubMed

    Lenvatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lenvatinib. Read the label on DailyMed ›

  • Liver problems Worth acting on Additional detail

    Cannabidiol (cbd)

    “Orally, cannabidiol oil has been associated with an elevation in liver transaminases and drug-induced liver injury (DILI). A meta-analysis of 12 clinical trials shows that taking cannabidiol daily is associated with approximately 5 times greater odds of DILI and 6 times greater odds of liver enzyme elevations when compared with placebo.”

    Cannabidiol (cbd) · Natural Medicines adverse-effect record, reported in myasthenia gravis.

    6 sources cited
    1. 113045. Lo LA, Christiansen A, Eadie L, et al. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med 2023;293(6):724-752. PubMed
    2. 110244. Souza JDR, Pacheco JC, Rossi GN, et al. Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022). Pharmaceutics 2022;14(12):2598. PubMed
    3. 109176. Atieh J, Maselli D, Breen-Lyles M, et al. Cannabidiol for functional dyspepsia with normal gastric emptying: A randomized controlled trial. Am J Gastroenterol 2022;117(8):1296-1304. PubMed
    4. 113034. Georgieva D, Langley J, Hartkopf K, et al. Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy. Epilepsy Behav 2023;141:109159. PubMed
    5. 107324. Davis BH, Beasley TM, Amaral M, et al. Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant Epilepsy. Clin Pharmacol Ther 2021;110(5):1368-1380. PubMed
    6. 107336. Kaufmann R, Aqua K, Lombardo J, Lee M. Observed Impact of Long-term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults. Cannabis Cannabinoid Res 2021. PubMed

    Lenvatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lenvatinib. Read the label on DailyMed ›

  • A higher chance of infection Worth acting on Additional detail

    Cannabidiol (cbd)

    Recorded for Cannabidiol (cbd) in the same Natural Medicines adverse-effect record shown under Liver problems above.

    Lenvatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lenvatinib. Read the label on DailyMed ›

  • Weight loss / Dry mouth / Reduced appetite Additional detail

    Cannabidiol (cbd)

    “Orally, cannabidiol has caused dry mouth in some patients in clinical research. In children and adults, cannabidiol oil has caused mild to moderate diarrhea, decreased appetite, weight loss, nausea, and vomiting. Diarrhea, decreased appetite, and weight loss or weight gain have been reported at a higher frequency with doses greater than 15-20 mg/kg daily.”

    Cannabidiol (cbd) · Natural Medicines adverse-effect record, reported in constipation.

    6 sources cited
    1. 89700. Consroe P, Sandyk R, Snider SR. Open label evaluation of cannabidiol in dystonic movement disorders. Int J Neurosci 1986;30(4):277-82. PubMed
    2. 105559. Velayudhan L, McGoohan K, Bhattacharyya S. Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis. PLoS Med. 2021;18(3):e1003524. PubMed
    3. 109177. Berger M, Li E, Rice S, et al. Cannabidiol for treatment-resistant anxiety disorders in young people: An open-label trial. J Clin Psychiatry 2022;83(5):21m14130. PubMed
    4. 110245. Dahlgren MK, Lambros AM, Smith RT, Sagar KA, El-Abboud C, Gruber SA. Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial. Commun Med (Lond) 2022;2(1): PubMed
    5. 110249. Zubcevic K, Petersen M, Bach FW, et al. Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment. Eur J Pain 2022.
    6. 97017. Devinsky O, Cross JH, Laux L, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet Syndrome. N Engl J Med. 2017 May 25;376(21):2011-2020. PubMed

    Lenvatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lenvatinib. Read the label on DailyMed ›

  • Sore throat Additional detail

    Cannabidiol (cbd)

    Recorded for Cannabidiol (cbd) in the same Natural Medicines adverse-effect record shown under Shortness of breath above.

    Lenvatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lenvatinib. Read the label on DailyMed ›

  • Low blood pressure Additional detail

    Cannabidiol (cbd)

    Recorded for Cannabidiol (cbd) in the same Natural Medicines adverse-effect record shown under Raised blood pressure above.

    Lenvatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lenvatinib. Read the label on DailyMed ›

  • Trouble sleeping Additional detail

    Cannabidiol (cbd)

    “Orally, cannabidiol has been most commonly reported to cause somnolence, sedation, dizziness, agitation, and fatigue, with a significantly higher incidence when used in conjunction with clobazam. Hallucinations, delusions, confusion, and slurred speech have been reported in a Poison Control Center report.”

    Cannabidiol (cbd) · Natural Medicines adverse-effect record, reported in cognitive function.

    6 sources cited
    1. 61989. Carlini EA, Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol 1981;21(8-9 Suppl):417S-27S. PubMed
    2. 100883. Laux LC, Bebin EM, Checketts D, et al. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Epilepsy Res. 2019;154:13-20. PubMed
    3. 102323. Klotz KA, Grob D, Hirsch M, Metternich B, Schulze-Bonhage A, Jacobs J. Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy. Front Neurol. 2019 Dec 10;10:1313. PubMed
    4. 103031. Chesney E, Oliver D, Green A, et al. Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology. 2020. PubMed
    5. 104884. Leehey MA, Liu Y, Hart F, et al. Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study. Cannabis Cannabinoid Res. 2020;5(4):326-336. PubMed
    6. 105493. Berger BA, Stolz U, Colvin J, Otten EJ. Epidemiology of cannabidiol related cases reported in the National Poison Data System - 2019-2020. Am J Emerg Med. 2021;48:218-223. PubMed

    Lenvatinib

    Listed in the ADVERSE REACTIONS section of the FDA label for Lenvatinib. Read the label on DailyMed ›

Showing the 10 most notable of 19 shared effects — ranked by how unusual each one is, not just whether both lists mention it.

Reported for Cannabidiol (cbd) but not commonly for Lenvatinib: dependence or withdrawal symptoms, memory problems, unsteadiness and hallucinations.

Effects for Lenvatinib come from the ADVERSE REACTIONS section of its FDA label; effects for Cannabidiol (cbd) come from the Natural Medicines adverse-effect record, quoted above. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Special populations

Cannabidiol (cbd) in Pregnancy & Breastfeeding

Pregnancy And Lactation Possibly Unsafe

When used orally. The US Food and Drug Administration (FDA) strongly advises against the use of cannabidiol during pregnancy. Cannabidiol products might contain delta-9-tetrahydrocannabinol (THC) or other contaminants such as pesticides, heavy metals, bacteria, and fungus, which can be dangerous to the child. Also, animal research shows that high levels of cannabidiol can damage the reproductive system of male offspring.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Everything else you take

See Every Supplement That Interacts With Lenvatinib

This page covers Cannabidiol (cbd) only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Lenvatinib page lists 71 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), American Hellebore (major), Arsenic (major), Asarabacca (major) and Beer (major).

By severity: 11 major · 50 moderate · 10 minor.

Open the Lenvatinib interaction page

How much people look this up

Where Cannabidiol (cbd) and Lenvatinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Cannabidiol (cbd)
Top half

#374 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Lenvatinib
Top half

#1,068 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Cannabidiol (cbd) reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Cannabidiol (cbd) and Lenvatinib records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Cannabidiol (cbd)

What is Cannabidiol (cbd)?

  • Anxiety and stress
  • Sleep problems
  • Chronic pain
  • Certain seizure disorders
  • Inflammation

CBD is a compound from the cannabis (hemp) plant that does not cause a 'high.' It has strong evidence only for certain rare seizure disorders (as a prescription drug), while most other popular uses are still backed by limited or early research. Product quality varies a lot, so talk with your pharmacist or doctor before using it, especially if you take other medicines.

Cannabis sativa · Cannabaceae · Flowers, leaves, and stalks of the hemp plant (extracted compound) · Oils and tinctures, capsules, gummies, topical creams, vape liquids, and a prescription solution

An interaction check asks whether these two react with each other — it does not ask whether Cannabidiol (cbd) is a good idea for someone in your situation. Here is what our Cannabidiol (cbd) record says about it on its own.

Cannabidiol (cbd): dosing

There is no single standard dose of CBD for general supplement use. The right amount can depend on the product, the reason for use, and the person. Because of this, it is best to follow the directions on the product label and start with a low amount.The only well-established dosing comes from the prescription CBD medicine used for seizures, which is carefully dosed by a doctor based on body weight. They can help you decide whether it is appropriate for you and review your other medicines for possible problems.

From our Cannabidiol (cbd) monograph — the full record covers uses, side effects and every documented interaction.

Read the full Cannabidiol (cbd) monograph & all interactions
Medication

About Lenvatinib

What Is Lenvatinib Used For?

Brand name: Lenvima

Lenvima (lenvatinib) is used to treat four types of cancer in adults. It treats locally recurrent or metastatic differentiated thyroid cancer (DTC) that no longer responds to radioactive iodine therapy. It is also approved for the first-line treatment of unresectable hepatocellular carcinoma (liver cancer).

For advanced renal cell carcinoma (kidney cancer), Lenvima is used in combination with pembrolizumab as a first-line treatment, or in combination with everolimus after one prior therapy. For advanced endometrial carcinoma (uterine cancer) with specific tumor markers (pMMR or not MSI-H), Lenvima is used in combination with pembrolizumab in patients whose disease has progressed after prior treatment and who are not candidates for surgery or radiation.

See full Lenvatinib drug information
Keep checking

Other Drugs & Cannabidiol (cbd)

Browse every other medication we’ve checked against Cannabidiol (cbd) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
1,051Moderate
0Minor
1,778No known interaction
1,051 Moderate 1,778 No interaction
Moderate

1,051 interactions

Showing 60 of 1,051 moderate interactions — see all 1,051 on the Cannabidiol (cbd) page.

No interaction 1,778 drugs checked — show the list

We also checked Cannabidiol (cbd) against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 1,778 medications checked with no known interaction — see the full Cannabidiol (cbd) list.

See the full Cannabidiol (cbd) interactions page
See every supplement checked against Lenvatinib, ranked by severity
Evidence & sources

Cannabidiol (cbd) References

The 93 references that drive our Cannabidiol (cbd) monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Rog, D. J., Nurmikko, T. J., Friede, T., and Young, C. A. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 9-27-2005;65(6):812-819. PubMed
  2. Perras, C. Sativex for the management of multiple sclerosis symptoms. Issues Emerg.Health Technol. 2005;(72):1-4.
  3. Rog, D. J., Nurmikko, T. J., and Young, C. A. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther. 2007;29(9):2068-2079.
  4. Consroe, P., Laguna, J., Allender, J., Snider, S., Stern, L., Sandyk, R., Kennedy, K., and Schram, K. Controlled clinical trial of cannabidiol in Huntington's disease. Pharmacol Biochem.Behav. 1991;40(3):701-708. PubMed
  5. Lynch, M. E. and Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br.J.Clin.Pharmacol. 2011;72(5):735-744. PubMed
  6. Richards, B. L., Whittle, S. L., and Buchbinder, R. Neuromodulators for pain management in rheumatoid arthritis. Cochrane.Database.Syst.Rev. 2012;1:CD008921. PubMed
  7. Carlini EA, Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol 1981;21(8-9 Suppl):417S-27S. PubMed
  8. Bergamaschi MM, Queiroz RH, Chagas MH, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology 2011;36(6):1219-26. PubMed
  9. Yamaori S, Kushihara M, Yamamoto I, Watanabe K. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective potent inhibitors of human CYP1 enzymes. Biochem Pharmacol 2010;79(11):1691-8.
  10. Yamaori S, Maeda C, Yamamoto I, Watanabe K. Differential inhibition of human cytochrome P450 2A6 and 2B6 by major phytocannabinoids. Forensic Toxicol 2011;29:117-24. DOI
  11. Yamaori S, Okamoto Y, Yamamoto I, Watanabe K. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Drug Metab Dispos 2011;39(11):2049-56. PubMed
  12. Yamaori S, Ebisawa J, Okushima Y, et al. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety. Life Sci 2011;88(15-16):730-6. PubMed
  13. Harvey DJ. Absorption, distribution, and biotransformation of the cannabinoids. Marijuana and Medicine. 1999;91-103. DOI
  14. Bornheim LM, Everhart ET, Li J, Correia MA. Characterization of cannabidiol-mediated cytochrome P450 inactivation. Biochem Pharmacol 1993;45(6):1323-31. PubMed
  15. Consroe P, Sandyk R, Snider SR. Open label evaluation of cannabidiol in dystonic movement disorders. Int J Neurosci 1986;30(4):277-82. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Cannabidiol (cbd) and Lenvatinib Together: Common Questions

Is it safe to take Cannabidiol (cbd) with Lenvatinib?
We do not list a known interaction between Cannabidiol (cbd) and Lenvatinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Cannabidiol (cbd) and Lenvatinib have any of the same side effects?
Yes — our sources link each of them separately to 10 of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
How was the Cannabidiol (cbd) and Lenvatinib combination checked?
Interactions in our licensed database are recorded against drug classes. Lenvatinib is filed under 4 classifications, and Cannabidiol (cbd) has documented interactions with 37 drug classes — none of Lenvatinib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Cannabidiol (cbd) interact with any other medications?
Yes. Cannabidiol (cbd) has 1,051 documented drug interactions in our database — Lenvatinib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Lenvatinib interact with any supplements?
Yes. Lenvatinib has documented interactions with 71 supplements in our database — Cannabidiol (cbd) is not one of them. The Lenvatinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Cannabidiol (cbd) monograph Uses, safety profile, and every drug interaction in one place Lenvatinib drug information The full plain-English guide to this medication Lenvatinib supplement interactions Every supplement checked against Lenvatinib, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 93 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Lenvatinib and Cannabidiol (cbd)?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.